Scientists have evidence that monoclonal antibodies they developed may provide the blueprint for effective treatments for Alzheimer’s disease and other neurodegenerative diseases, such as Parkinson’s disease.

Source: Novel monoclonal antibodies show promise for Alzheimer’s disease treatment: Parkinson’s disease may also be treated with potential therapy — ScienceDaily